Teva Prevails As Judge Rules Generic Cancer Drugs Infringe
A Delaware federal judge ruled Monday that planned generic versions of the cancer drug Bendeka from four companies infringe a total of five patents owned by Eagle Pharmaceuticals and licensed to...To view the full article, register now.
Already a subscriber? Click here to view full article